Diagnosing a C. diff infection requires two things: symptoms of diarrhea (three or more unformed stools in 24 hours) and a positive stool test confirming the bacteria or its toxins. Neither one alone is enough. Loose stools without a positive test could be something else entirely, and a positive test without symptoms may just mean you’re carrying the bacteria harmlessly. This two-part requirement shapes the entire diagnostic process.
When Testing Is Appropriate
Not every case of diarrhea warrants a C. diff test. Guidelines from the Infectious Disease Society of America and the Society for Healthcare Epidemiology of America specify that testing should only be considered when a patient has three or more unexplained, unformed stools within 24 hours and is not currently taking laxatives. The stool itself needs to be liquid or very loose, scoring a 6 or 7 on the Bristol Stool Scale (think mushy to entirely watery). Labs will actually check the consistency of your sample and may reject it if the stool is formed, since that pattern doesn’t fit a C. diff infection.
Other exclusion criteria matter too. If you’ve taken laxatives or motility agents within the past 48 hours, testing isn’t reliable because those drugs cause loose stools on their own. If you’ve already been tested for C. diff in the last 14 days, a repeat test within that window is generally not recommended. And once someone has tested positive, retesting to confirm the infection has cleared is discouraged because tests can stay positive for six weeks or longer, even after the infection has resolved.
The Stool Tests Used
There are several types of stool tests for C. diff, and most hospitals now use a combination rather than relying on a single method. Each test has different strengths, and understanding those tradeoffs explains why a multi-step approach has become standard.
GDH Screening
The glutamate dehydrogenase test detects a protein that C. diff produces in large amounts. It’s fast and very sensitive, meaning it rarely misses the bacteria when it’s present. However, it can’t tell whether the bacteria are actually producing harmful toxins. A negative GDH result is reliable enough to rule out C. diff, but a positive result needs further confirmation.
Toxin Testing
Toxin enzyme immunoassays detect the specific poisons (toxins A and B) that C. diff releases to damage the colon lining. These toxins are what actually make you sick, so a positive toxin test is strong evidence of a true infection. The problem is sensitivity: toxin tests miss a significant number of real infections. Studies have found sensitivity as low as 33 to 65% compared to culture, meaning the test fails to detect toxins in roughly one-third to two-thirds of confirmed cases. Among patients with mild C. diff, only about 49% tested positive by toxin testing, and even among patients with severe disease, only 58% tested positive. So a negative toxin result doesn’t mean you’re in the clear.
PCR (Molecular Testing)
Nucleic acid amplification tests, commonly called PCR tests, detect C. diff’s genetic material. These are the most sensitive option, picking up nearly 100% of cases in studies. The tradeoff is that PCR can detect C. diff even when the bacteria are present at low levels and not actively causing disease. This means PCR alone can lead to overdiagnosis, flagging people who are carriers rather than truly infected.
How Multi-Step Testing Works
Because no single test is both highly sensitive and highly specific, current guidelines recommend combining tests in a stepwise algorithm. The most common approaches are:
- GDH plus toxin, with PCR as a tiebreaker: The GDH screen runs first. If negative, C. diff is ruled out. If positive, a toxin test follows. If the toxin test is also positive, the diagnosis is confirmed. If the GDH is positive but the toxin test is negative, a PCR test decides whether the result is truly negative or a missed case.
- PCR plus toxin: A PCR test runs alongside a toxin test. If both are positive, the diagnosis is clear. If the PCR is positive but the toxin is negative, the result is harder to interpret and may reflect colonization rather than active infection.
The specific algorithm your hospital uses depends on whether the facility has pre-agreed criteria for when doctors can order the test. When hospitals leave testing decisions entirely to individual doctors (without institutional screening criteria), guidelines favor multi-step algorithms over PCR alone to reduce false positives from asymptomatic carriers.
Why Asymptomatic Carriers Complicate Testing
A substantial number of hospitalized patients carry C. diff in their gut without any symptoms. Lab tests cannot distinguish between someone who is colonized harmlessly and someone with an active infection. This is why guidelines emphasize that testing should only happen when a patient has diarrhea. Testing asymptomatic people can identify carriers for infection-control purposes (isolating them to prevent spread), but a positive result in someone without symptoms should not lead to treatment.
Colonoscopy in Severe or Unclear Cases
Stool tests handle the vast majority of diagnoses, but in severe or atypical cases where stool results are inconclusive, a colonoscopy can provide visual confirmation. The hallmark finding is pseudomembranous colitis: raised yellow-white plaques scattered across the colon lining. These plaques can be up to two centimeters across and are tightly stuck to the tissue. In mild cases, the plaques appear as isolated patches between areas of normal-looking tissue. In severe disease, they can merge to cover the entire colon surface. This visual pattern is distinctive enough to confirm C. diff even without a positive stool test, though colonoscopy is reserved for situations where it’s genuinely needed.
Conditions That Mimic C. Diff
Diarrhea has many causes, and jumping straight to C. diff testing isn’t always the right call. Antibiotic-associated diarrhea can happen without C. diff involvement. Parasitic infections and traveler’s diarrhea produce similar symptoms. Irritable bowel syndrome can cause chronic loose stools that overlap with C. diff presentations. One especially tricky scenario is post-infectious irritable bowel syndrome, where bowel habits remain disrupted long after an initial gut infection has cleared.
Inflammatory bowel disease deserves special attention. Patients with Crohn’s disease or ulcerative colitis are at higher risk for C. diff and can have flares that look identical to a C. diff infection. Testing for C. diff during an IBD flare is considered essential because treating an IBD flare with immune-suppressing drugs while an undetected C. diff infection is active can be dangerous.
Diagnosing a Recurrence
C. diff comes back frequently. A recurrence is generally defined as a new episode of symptoms with a positive test occurring within eight weeks of a previous episode. The recurrence could be a relapse of the original strain or a completely new infection with a different strain, though from a diagnostic standpoint, the approach is the same: new symptoms plus a new positive stool test. As noted earlier, retesting within a short window after a known positive is unreliable because the test may still be reacting to leftover bacterial material rather than active disease. The return of diarrhea is the key clinical signal that prompts re-evaluation.
What the Sample Collection Looks Like
If your doctor orders a C. diff test, you’ll provide a stool sample in a collection container. The sample needs to reach the lab within two hours if kept at room temperature. Rectal swabs are not acceptable for C. diff testing. For patients older than two, samples collected from a diaper are also excluded. The lab checks consistency before processing, and if the stool is formed, the test may be cancelled and sent back for the ordering provider to reconsider.